Bruce Eaton, Ph.D.

Bruce Eaton, Ph.D.

Former Executive Vice President and Chief Business OfficeratEditas Medicine· In proxies 2021–2023

Pay in FY2023-52% from the year before · Editas Medicine stock +14.2% the same year

Bruce Eaton, Ph.D. was paid $1.3M in FY2023 (Dec), down 52%. Editas Medicine stock rose 14.2% that year.

Pay$100 in the stock at the end of FY20 → $14
Pay is from the Summary Compensation Table of each Editas Medicine proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Editas MedicinePublic company · 5 yr
    • Former Executive Vice President and Chief Business Officer2021 – Present · 5 yrStock in role -96%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?